Anavex Life Sciences
AVXL
#6581
Rank
โ‚น40.12 B
Marketcap
โ‚น473.16
Share price
-2.08%
Change (1 day)
-21.39%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น0.98 B

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are โ‚น0.98 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-09-30โ‚น1.04 B25.4%
2022-09-30โ‚น0.83 B3.71%
2021-09-30โ‚น0.80 B49.16%
2020-09-30โ‚น0.53 B50.91%
2019-09-30โ‚น0.35 B26.43%
2018-09-30โ‚น0.28 B20.33%
2017-09-30โ‚น0.23 B9.77%
2016-09-30โ‚น0.21 B21.68%
2015-09-30โ‚น0.17 B-60.28%
2014-09-30โ‚น0.44 B147.08%
2013-09-30โ‚น0.17 B16.98%
2012-09-30โ‚น0.15 B131.14%
2011-09-30โ‚น66.04 M-55.21%
2010-09-30โ‚น0.14 B-28.12%
2009-09-30โ‚น0.20 B88.07%
2008-09-30โ‚น0.10 B492.49%
2007-09-30โ‚น18.41 M1335.67%
2006-09-30โ‚น1.28 M8.04%
2005-09-30โ‚น1.18 M931.06%
2004-09-30โ‚น0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น7.65 B 675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น79.53 B 7,965.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.92 B 906.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.82 B-16.39%๐Ÿ‡บ๐Ÿ‡ธ USA